SEC Form 4/A · accession 0000899243-18-029698

Fuse Medical, Inc. · FZMD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

This is an amendment (Form 4/A). It replaces an earlier filing for the same period.

Reporting owner

10% Owner

Period of report

Aug 1, 2018

Accepted (ET)

Nov 27, 2018 · 7:01 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000319016

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1	Aug 1, 2018	P	2,539,474	$0.76	A	6,539,474	D
Common Stock^F2	Oct 4, 2018	P	72,139	$0.68	A	6,611,613	D

No Table II lines on this filing.

F1This Form 4/A amends the Form 4 filed by Reeg Medical Industries, Inc. ("RMI") on August 3, 2018, to correct the number of shares of common stock, par value $0.01 (the "Common Stock"), of the Fuse Medical, Inc., a Delaware corporation (the "Company"), that Reeg received pursuant to that certain Securities Purchase Agreement, dated July 30, 2018 (the "Maxim Purchase Agreement"), by and between the Company, Palm Springs Partners, LLC d/b/a Maxim Surgical, a Texas limited liability company ("Maxim"), RMI, Mr. Amir David Tahernia, an individual ("Tahernia", together with RMI, the "Sellers"), and Tahernia in his capacity as the representative of the Sellers (the "Sellers Representative"). The Company made a calculation error when computing the number of shares of Common Stock issued to RMI, and corrected the number in its Current Report on Form 8-K/A filed with the Securities and Exchange Commission (the "SEC") on November 16, 2018 (the "Maxim Form 8-K/A").
F2On October 4, 2018, the Company issued 72,139 shares of Common Stock to RMI, which represents RMI's pro rata share of the agreed-upon purchase price adjustment pursuant to Pursuant to the Maxim Purchase Agreement, as reported in the Maxim Form 8-K/A.